Opioids Market Analysis, Production Cost And Development Status And Forecast 2025

The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026.

Opioids are drugs that stimulate the brain to produce a variety of effects, including pain relief.The term opioid refers to all substances (exogenous or endogenous) that possess morphine-like properties.

These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.Request For Report Sample:https://www.trendsmarketresearch.com/report/sample/13363 The growth of the global opioids market is driven by alarming increase in incidence of orthopedic diseases & chronic pain.

Furthermore, rise in disposable income and surge in global geriatric population are expected to propel the growth of the global opioids market.However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market.

On the contrary, increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future.

Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone.

Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023Market Highlights:The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.

Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.

According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years.

However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.Intended AudiencePharmaceutical CompaniesResearch InstitutesHospitalsAcademic InstitutesAvail a Free Sample@ https://www.medgadget.com/2019/09/orthodontic-supplies-market-2019-services-size-technology-key-players-growth-analysis-future-trends-demand-global-share-and-regional-development-and-forecast-to-2023.html Segment analysisThe global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids.

The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.

On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.Regional AnalysisThe Americas is expected to hold the largest share of the global opioids market.

The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.

The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years. However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.

Global Opioids Market: Competitive Landscape

Some of the key players in the global Opioids Market are

• Mallinckrodt (Surrey)
• Vertice Pharma LLC (UK)
• Janssen Global Services, LLC (US)
• Egalet Corporation (US)
• Sun Pharmaceutical Industries Ltd (India)
• West-Ward Pharmaceuticals Corporation (Jordan)
• Purdue Pharma L.P. (US)
• Allergan Inc. (US)
• Teva Pharmaceutical Industries Ltd (Israel)
• Boehringer Ingelheim GmbH (Germany)
• Sanofi SA (France), Pfizer Inc. (US)

Opioids Market Segmentation

The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.

Opioids Market Regional Analysis

The Americas is expected to hold the largest share of the global opioids market. This is owing to rising intravenous usage of opioids in the region. Also, high awareness among people regarding the medical uses of opioids is expected to drive the market growth in the region.

Europe showed a considerable amount of growth in the market due to increasing palliative care facilities and reformed regulations for the prescription of opioids. Asia-Pacific is estimated to be the fastest growing region in the global market. Populace demographics and increased availability of effective opioid medications are likely to be the key factors for the growth of Asia-Pacific opioids market during the forecast period. South Korea held a share of 6% in the Asia-Pacific opioids market in 2017. Also, the Middle East and Africa region is expected to steadily grow owing to the rising number of opioid manufacturers in the North African region.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.4.3 Market Structure

3. Research Methodology

3.1 Primary Research Methodology

3.2 Secondary Research Methodology

3.3 Market Size Estimation

3.4 Forecast Model

4. Market Dynamics

    TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/opioids-market-7626

About US:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2027Market HighlightsThe global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.

Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.

According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years.

The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.

On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.Regional AnalysisThe Americas is expected to hold the largest share of the global opioids market.

Also, high awareness among people regarding the medical uses of opioids is expected to drive the market growth in the region.Europe showed a considerable amount of growth in the market due to increasing palliative care facilities and reformed regulations for the prescription of opioids.

Opioids Drug Market report published by Value Market Research, which studies the future outlook of the market.

It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the opioids drug market include Acura Pharmaceuticals, Biodelivery Sciences International Inc., Cipher Pharmaceuticals Inc, Allergan, Collegium Pharmaceutical Inc., Daiichi Sankyo, Hikma Pharmaceuticals plc, Indivior Inc., Janssen Pharmaceuticals Inc., and Johnson Johnson.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Opioids Drug Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/opioids-drug-market/download-sampleMarket DynamicsThe rising prevalence of chronic diseases that cause chronic pain, such as cancer pain, lower back pain, and arthritis, is the primary market driver for the growth of the opioids drug market.

Furthermore, an increase in disposable income and a surge in the geriatric population are some of the factors that will boost the market growth.

However, the legalization of cannabis as an alternative to opioids may hamper the market growth of opioids.

This report on the Global Opioids Market provides a global 360-degree perspective of the industry while taking into consideration historical data as well as providing accurate estimations of the future scope of the market.

It highlights key factors impacting the market growth and also contains an entire section describing the segmentation of the market on the basis of several factors such as types, applications at a high level and also points out the segments leading the market.

This makes it easier for the stakeholders of the report to utilize this information and incorporate changes in their business policies and be well informed about the market dynamics.

It also provides an insight into the competitive landscape of the market highlighting key competitors, major manufacturers dominating the Opioids Market, while also providing an analysis of the market share and revenue generation figures.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/opioids-market-2195Global Opioids Market Competitive Analysis:Purdue Pharma L.PWest-Ward Pharmaceuticals CorporationJanssen Pharmaceuticals, Inc.West-Ward Pharmaceuticals CorporationSanofi-Aventis S.A.Pfizer, Inc.ALLERGAN (Actavis)Sun Pharmaceutical Industries LimitedGrunenthal GmbhDrivers & ConstraintsThe report largely stresses on the importance of market dynamics in understanding the Opioids Market industry.

Sales revenues, population, production rates, consumption rates, existence of key manufacturers in regions are all points that have been touched base upon in the report providing an overall comparison of each of the regions covered in the report.

Additionally, the report also calls out regions that have showed maximum growth in the past as well as regions that emerged as leaders of the market in historic years.

Global Opioids Market is anticipated to reach USD 34.96 billion by 2025.

However, when opioids are taken in high quantity it leads to risk of mortality and dependence in patients.

To treat severe and moderate pain opioids are mainly used.In addition, the prevalence of disease situations with long-lasting pain, such as cancer, arthritis, fibromyalgia, and lower back pain is propelling the market.

Significant increase in road accidents and trauma combined with repeatedly growing cases of surgical methods are driving the demand for opioid-based pain management solutions.

On the other hand, legalization and emergence of cannabis as a substitute to opioids obstruct the development of the opioids market and it is anticipated to grow at a significant CAGR of 4.8% in the upcoming period as the scope, product types, and its applications are increasing across the globe.Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/opioids-market/request-sampleOpioids Market may be explored by Product Outlook, applications, by dosage forms, and geography.

Opioids Market may be explored by Product Outlook as Immediate-Release/Short-Acting, could explored as (Codeine, Opioid, Oxycodone, Hydrocodone, Propoxyphene, Fentanyl, Hydroxymorphone, Morphine, Oxymorphone, Other IR), Extended-Release/Long-Acting Opioid could explore as (Methadone, Oxycodone, Fentanyl, Morphine, Oxymorphone, Hydromorphone, Tapentadol, Hydrocodone, Buprenorphine, Other ER).The “Extended-release/Long-Acting Opioid” segment dominated the market in 2016 and is anticipated to maintain its dominance by 2025 due to factors such as growth of innovative dose distributers such as high usage of these constituents for chronic pain organization and transdermal patches.